571 monographs from the DSNC Iraq Drug Guide, structured and searchable. 11 clinical appendices — including a trade name directory, interaction checker, and pregnancy safety engine. Fully offline after installation. Deterministic results throughout: no AI inference, no generated text.
Verify by email · 7 days full access · No passwords · Then 10,000 IQD for 3 years
Designed for real hospital conditions — intermittent connectivity, shared devices, and no tolerance for unreliable data.
Two appendices come from the printed Iraq Drug Guide source material. Nine additional clinical tools were developed from the same structured dataset. All results are deterministic — sourced directly from monograph fields, with no external data or generated text.
No App Store. No download file. Works on any modern phone or computer.
Visit idg-logbook.enki-clinical.com in Chrome on your Android phone.
A banner at the bottom reads "Install app — works offline". Tap Install.
IDG Logbook appears on your home screen and opens full-screen without browser chrome.
Visit idg-logbook.enki-clinical.com in Safari. Installation is not available through Chrome on iOS.
Tap the Share icon at the bottom of Safari — the box with an upward arrow.
Scroll the Share sheet and tap "Add to Home Screen". Confirm and tap Add.
Visit idg-logbook.enki-clinical.com in Chrome or Microsoft Edge.
Click the install icon (⊕) in the right side of the address bar.
IDG Logbook appears in your Start Menu or Applications folder and runs in its own window.
No subscription. No automatic renewal. All updates and new appendices included during the license period.
Contact Dr. Amir Fadhel directly. License keys are issued personally, within 24 hours of payment confirmation.
Healthcare organizations that use IDG Logbook and wish to be formally acknowledged within the application — or that wish to explore a defined collaboration — are welcome to contact the developer. Relevant arrangements may include hospitals that want to be listed as verified user institutions, academic departments interested in a teaching or reference arrangement, or pharmaceutical distributors operating in Iraq who wish to ensure their locally available products are accurately represented in the formulary data.
Any collaboration is evaluated on the condition that it carries no influence over the neutrality of clinical content. Acknowledged partners are disclosed transparently within the application. The application's data and decision logic remain fully independent of any external relationship.